IFNG and cancer: We recognize that this model may overstated the role of PDL-1 expression and further studies will be necessary to elucidate and fine-tune the pharmacodynamics of this interactions in conditions closer to the natural behavior of cancer cells exposed to IFN-γ produced by CAR-T cells.